Scholars Central

EditorialPublished 29 Jul 2024

Non-invasive Diagnostic Instruments for Cancer Tracking: Liquid Biopsies

Authors: Rahel Shouman

Department of Biology, University of Guyana, Turkeyen Campus, Guyana

Journal of Orthopedic Oncology

Volume 10 · Issue 4 · Pages 1–2

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Liquid biopsies have emerged as a transformative non-invasive diagnostic tool in oncology, providing a dynamic and comprehensive approach to cancer detection and monitoring. By analyzing biomarkers such as circulating tumor cells (CTCs), cell-free DNA (cfDNA), circulating tumor DNA (ctDNA), and exosomes in blood samples, liquid biopsies offer significant advantages over traditional tissue biopsies, including real-time monitoring, early detection, and a complete view of tumor heterogeneity. This review explores the types of biomarkers utilized in liquid biopsies, their clinical applications in cancer screening, treatment monitoring, and personalized medicine, as well as the challenges and future directions of this innovative technology. As research and technological advancements continue, liquid biopsies are poised to revolutionize personalized cancer care, improving patient outcomes and quality of life.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Orthopedic Oncology.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Orthopedic Oncology
  • SubjectOncology & Cancer
  • SubjectOrthopaedics
  • BylineArticles whose byline prints “Rahel Shouman”